Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia

Fabio Giuseppe Liberante; Tara Pouryahya; Mary-Frances McMullin; Shu-Dong Zhang*; Kenneth Ian Mills*

Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia

Fabio Giuseppe Liberante, Tara Pouryahya, Mary-Frances McMullin, Shu-Dong Zhang*, Kenneth Ian Mills*

Research output: Contribution to journal › Article › peer-review

8 Downloads (Pure)

Original language	English
Journal	Oncotarget
Volume	7
Issue number	6
Publication status	Published - 28 Dec 2015

Keywords

myelodysplastic syndromes (MDS)
acute myeloid leukemia (AML)
bromocriptine
re-purposed
therapy

Access to Document

2015-OncoTarget-6773-102602-4-PBFinal published version, 3.21 MB

Cite this

@article{63c950ee3b3640d8816cf5af351b55c5,

title = "Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia",

keywords = "myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), bromocriptine, re-purposed, therapy",

author = "Liberante, {Fabio Giuseppe} and Tara Pouryahya and Mary-Frances McMullin and Shu-Dong Zhang* and Mills*, {Kenneth Ian}",

year = "2015",

month = dec,

day = "28",

language = "English",

volume = "7",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "6",

}

Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia. / Liberante, Fabio Giuseppe; Pouryahya, Tara; McMullin, Mary-Frances; Zhang*, Shu-Dong; Mills*, Kenneth Ian.

In: Oncotarget, Vol. 7, No. 6, 28.12.2015.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia

AU - Liberante, Fabio Giuseppe

AU - Pouryahya, Tara

AU - McMullin, Mary-Frances

AU - Zhang, Shu-Dong

AU - Mills, Kenneth Ian

PY - 2015/12/28

Y1 - 2015/12/28

KW - myelodysplastic syndromes (MDS)

KW - acute myeloid leukemia (AML)

KW - bromocriptine

KW - re-purposed

KW - therapy

M3 - Article

VL - 7

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 6

ER -